Neurogene (NGNE) director Noonberg received 7,700 Stock Option (Right to Buy)

Insider transactions reported

Sarah B. Noonberg (director at Neurogene Inc., NGNE) reported that they received 7,700 Stock Option (Right to Buy) on Jun 14, 2024.

Reporting person

Noonberg Sarah B.

Options and other derivatives

Holdings before and after

• Stock Option (Right to Buy): 0 to 7,700 direct

Footnotes from the filing

1. 1. This option represents a right to purchase 7,700 shares of the Issuer's common stock, which will vest in its entirety on the earlier of (a) the first anniversary of the date of grant or (b) the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such applicable vesting date.

Transaction codes in this filing

Grant or award:

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ